On this basis, Savastano et al. speculated that in psoriasis chronic inflammation might be an important modulator of low IGF-I status and that, similarly to other pathological conditions, low IGF-I status could be added as a further possible mechanistic link between psoriasis and associated metabolic comorbidities [34]. The gene discussed is IGF1; the disease is psoriasis.